Skip to main content
Granules India Ltd. logo

Granules India Ltd. — Investor Relations & Filings

Ticker · GRANULES ISIN · INE101D01020 LEI · 335800HJF1KE335ASX37 BSE.NS Manufacturing
Open in API
Filings indexed 954 across all filing types
Latest filing 2025-01-08 Regulatory Filings
Country IN India
Listing BSE.NS GRANULES

About Granules India Ltd.

https://granulesindia.com/

Granules India Ltd. is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The organization maintains a significant global presence through the large-scale production of essential molecules, including Paracetamol, Ibuprofen, Metformin, Methocarbamol, and Guaifenesin. Its business model emphasizes a complete value chain approach, from core chemical synthesis to final product packaging, ensuring operational efficiency and supply chain security. The company serves a diverse international clientele across more than 75 countries, utilizing advanced manufacturing facilities that comply with global regulatory standards. Key strengths include high-volume production capabilities, cost leadership, and a focus on delivering consistent quality in high-demand therapeutic areas.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-08 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 99 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous filings without substantive content.
2025-01-08 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 92 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and defaults to the fallback category for miscellaneous filings.
2024-12-26 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges regarding a 'Letter of Confirmation' issued due to the loss of a share certificate of a shareholder. It references compliance with SEBI Listing Regulations and provides details about the shareholder and shares involved. The document is brief (1454 characters) and serves as an intimation or regulatory announcement rather than a full report or financial statement. It does not contain financial data, management discussion, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-17 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing FDA approval for a pharmaceutical product by Granules India Limited. It is addressed to stock exchanges and intended for public dissemination. The content focuses on regulatory approval news and company achievements rather than financial results, management changes, or detailed financial data. The document length is about 6,221 characters, which is typical for a press release. There is no indication of financial statements, earnings data, or detailed report content. Therefore, this document fits best under the category of a Capital/Financing Update (CAP) or Regulatory Filings (RNS). However, since it is a press release about a regulatory approval and not a financial or capital structure update, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2024-12-17 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the loss of a share certificate by a shareholder. It references SEBI regulations related to share certificate loss and the issuance of a letter of confirmation instead of a physical certificate. The content is regulatory in nature, informing about a specific event concerning share certificates, but it does not contain financial data, management discussion, or report content. It is not an annual report, earnings release, or any financial report. It is also not a director's dealing or share issue announcement. Given the nature of the document as a regulatory compliance notification about share certificate loss, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.